Related references
Note: Only part of the references are listed.Pan-cancer stratification of solid human epithelial tumors and cancer cell lines reveals commonalities and tissue-specific features of the CpG island methylator phenotype
Francisco Sanchez-Vega et al.
EPIGENETICS & CHROMATIN (2015)
Epigenetic biomarkers in esophageal cancer
Andrew M. Kaz et al.
CANCER LETTERS (2014)
Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin
Katherine A. Hoadley et al.
CELL (2014)
The BRAF Oncoprotein Functions through the Transcriptional Repressor MAFG to Mediate the CpG Island Methylator Phenotype
Minggang Fang et al.
MOLECULAR CELL (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
RNF43 is frequently mutated in colorectal and endometrial cancers
Marios Giannakis et al.
NATURE GENETICS (2014)
Integrated analysis of germline and somatic variants in ovarian cancer
Krishna L. Kanchi et al.
NATURE COMMUNICATIONS (2014)
Pan-cancer patterns of DNA methylation
Tania Witte et al.
GENOME MEDICINE (2014)
A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype
Ryan W. Serra et al.
ELIFE (2014)
A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data
Andrew E. Teschendorff et al.
BIOINFORMATICS (2013)
Identifying Mendelian disease genes with the Variant Effect Scoring Tool
Hannah Carter et al.
BMC GENOMICS (2013)
The CpG Island Methylator Phenotype: What's in a Name?
Laura A. E. Hughes et al.
CANCER RESEARCH (2013)
Interplay between the Cancer Genome and Epigenome
Hui Shen et al.
CELL (2013)
Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines
Francisco Sanchez-Vega et al.
EPIGENETICS (2013)
Dynamic DNA methylation across diverse human cell lines and tissues
Katherine E. Varley et al.
GENOME RESEARCH (2013)
RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary
Georgina L. Ryland et al.
JOURNAL OF PATHOLOGY (2013)
Expanding the spectrum of IDH1 mutations in gliomas
Ruta Gupta et al.
MODERN PATHOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Tumour heterogeneity in the clinic
Philippe L. Bedard et al.
NATURE (2013)
Emerging landscape of oncogenic signatures across human cancers
Giovanni Ciriello et al.
NATURE GENETICS (2013)
TSGene: a web resource for tumor suppressor genes
Min Zhao et al.
NUCLEIC ACIDS RESEARCH (2013)
Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma
Xiaomo Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
The CpG island methylator phenotype in colorectal cancer: Progress and problems
Laura A. E. Hughes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)
CpG Island Methylator Phenotype-Positive Tumors in the Absence of MLH1 Methylation Constitute a Distinct Subset of Duodenal Adenocarcinomas and Are Associated with Poor Prognosis
Tao Fu et al.
CLINICAL CANCER RESEARCH (2012)
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
Toshinori Hinoue et al.
GENOME RESEARCH (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Absolute quantification of somatic DNA alterations in human cancer
Scott L. Carter et al.
NATURE BIOTECHNOLOGY (2012)
DNA methylation profiling in the clinic: applications and challenges
Holger Heyn et al.
NATURE REVIEWS GENETICS (2012)
Differential Analysis of Ovarian and Endometrial Cancers Identifies a Methylator Phenotype
Diana L. Kolbe et al.
PLOS ONE (2012)
CpG island methylator phenotype and Helicobacter pylori infection associated with gastric cancer
Ji-Bin Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns
Duncan Sproul et al.
GENOME BIOLOGY (2012)
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
Jorja D. Warren et al.
BMC MEDICINE (2011)
DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses
Andrew M. Kaz et al.
EPIGENETICS (2011)
Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer
Justin J-L Wong et al.
MODERN PATHOLOGY (2011)
Cancer epigenetics reaches mainstream oncology
Manuel Rodriguez-Paredes et al.
NATURE MEDICINE (2011)
A decade of exploring the cancer epigenome - biological and translational implications
Stephen B. Baylin et al.
NATURE REVIEWS CANCER (2011)
Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features
Pei Woon Ang et al.
BMC CANCER (2010)
Orphan CpG Islands Identify Numerous Conserved Promoters in the Mammalian Genome
Robert S. Illingworth et al.
PLOS GENETICS (2010)
Epigenetic Events in Gastrointestinal Cancer
Florin M. Selaru et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Linking DNA methylation and histone modification: patterns and paradigms
Howard Cedar et al.
NATURE REVIEWS GENETICS (2009)
Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa
N. J. Belshaw et al.
BRITISH JOURNAL OF CANCER (2008)
Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer
Reo Maruyama et al.
CARCINOGENESIS (2008)
CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer
Zeyi Liu et al.
LUNG CANCER (2008)
Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma
M. S. Kim et al.
ONCOGENE (2008)
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer
Lanlan Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features
K. Harada et al.
BRITISH JOURNAL OF CANCER (2007)
18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high
Shuji Ogino et al.
BMC CANCER (2007)
Epigenetic gene silencing in cancer: the DNA hypermethylome
Manel Esteller
HUMAN MOLECULAR GENETICS (2007)
Epigenetic stem cell signature in cancer
Martin Widschwendter et al.
NATURE GENETICS (2007)
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer
Yeshayahu Schlesinger et al.
NATURE GENETICS (2007)
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing
Joyce E. Ohm et al.
NATURE GENETICS (2007)
Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer
Kimishige Akino et al.
CANCER SCIENCE (2007)
CpG island methylator phenotype-low (CIMP-Low) in colorectal cancer:: Possible associations with male sex and KRAS mutations
Shuji Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia
Jose Roman-Gomez et al.
CLINICAL CANCER RESEARCH (2006)
Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus
Mingzhou Guo et al.
CLINICAL CANCER RESEARCH (2006)
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
Daniel J. Weisenberger et al.
NATURE GENETICS (2006)
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies
S. Ogino et al.
GUT (2006)
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
BE Bernstein et al.
CELL (2006)
CpG island hypermethylation in progression of esophageal and gastric cancer
F Sato et al.
CANCER (2006)
A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters
S Saxonov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer
WS Samowitz et al.
GASTROENTEROLOGY (2005)
Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers
T Etoh et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Opinion - CpG island methylator phenotype in cancer
JP Issa
NATURE REVIEWS CANCER (2004)
Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors
M Lombaerts et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Epigenetics in human disease and prospects for epigenetic therapy
G Egger et al.
NATURE (2004)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Genetics supersedes epigenetics in colon cancer phenotype
K Yamashita et al.
CANCER CELL (2003)
Frequent CpG island methylation in serrated adenomas of the colorectum
SJ Park et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
The fundamental role of epigenetic events in cancer
PA Jones et al.
NATURE REVIEWS GENETICS (2002)
CpG island methylation in aberrant crypt foci of the colorectum
AOO Chan et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes
G Strathdee et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
